Skip to main content

ASCPT 2025 Annual Meeting Main banner

Browse by Poster Title

Browse by Poster Title

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#

O
PII-098
ON TRANSLATING PHYSIOLOGICALLY BASED PHARMACOKINETICS INTO CLINICAL CARE: REAL-WORLD PREDICTABILITY OF VALPROATE THERAPEUTIC DRUG MONITORING.

Favorite
PI-034
ONCOLOGIST CONSIDERATIONS WHEN CHOOSING BETWEEN 200 MG EVERY-3-WEEK VERSUS 400 MG EVERY-6-WEEK DOSING OF PEMBROLIZUMAB MONOTHERAPY WITHIN UPMC HILLMAN CANCER CENTER NETWORK

Favorite
PII-034
OPTIMIZING DOSE SELECTION FOR CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY IN THE TREATMENT OF PATIENTS WITH CANCER : A SYSTEMATIC REVIEW OF MECHANISTIC IN SILICO MODELS.

Favorite
PI-006
OPTIMIZING REGIMEN COMBINATIONS FOR TUBERCULOSIS DRUG DEVELOPMENT.

Favorite
PI-121
OPTIMIZING THE FIRST-IN-HUMAN STUDY DESIGN FOR BIOLOGICS EXHIBITING TARGET-MEDIATED DRUG DISPOSITION

Favorite
PI-107
OPTIMIZING VANCOMYCIN DOSING REGIMENS FOR OBESE PATIENTS

Favorite